A large-scale genetic correlation scan between rheumatoid arthritis and human plasma protein. Issue 2 (23rd February 2022)

• Record Type: Journal Article
• Authors: Luo, Pan; Cheng, Shiqiang; Zhang, Feng; Feng, Ruoyang; Xu, Ke; Jing, Wensen; Xu, Peng
• Is Part Of: Bone & joint research. Volume 11:Issue 2(2022)
• Page Start: 134
• Page End: 142
• Publication Date: 2022-02-23
• Subjects: Rheumatoid arthritis -- Plasma protein -- Genetic correlation -- transport protein -- correlation coefficient -- pathogenesis -- blood -- single nucleotide polymorphisms (SNPs) -- joint diseases -- randomized controlled trials -- variance -- regression analysis; Musculoskeletal system -- Periodicals; 573.705
• DOI: 10.1302/2046-3758.112.BJR-2021-0270.R1
• Languages: English
• ISSNs: 2046-3758

Abstract

Abstract : Aims: The aim of this study was to explore the genetic correlation and causal relationship between blood plasma proteins and rheumatoid arthritis (RA). Methods: Based on the genome-wide association studies (GWAS) summary statistics of RA from European descent and the GWAS summary datasets of 3, 622 plasma proteins, we explored the relationship between RA and plasma proteins from three aspects. First, linkage disequilibrium score regression (LD score regression) was applied to detect the genetic correlation between RA and plasma proteins. Mendelian randomization (MR) analysis was then used to evaluate the causal association between RA and plasma proteins. Finally, GEO2R was used to screen the differentially expressed genes (DEGs) between patients with RA and healthy controls. Results: We found that seven kinds of plasma proteins had genetic correlations with RA, such as Soluble Receptor for Advanced Glycation End Products (sRAGE) (correlation coefficient = 0.2582, p = 0.049), vesicle transport protein USE1 (correlation coefficient = 0.1337, p = 0.018), and spermatogenesis-associated protein 20 (correlation coefficient = 0.3706, p = 0.018). There was a significant causal relationship between sRAGE and RA. By comparing the genes encoding seven plasma proteins, we found that only USE1 was a DEG associated with RA. Conclusion: Our study identified a set of candidate plasma proteins that showed signals correlated with RA. Since the results of this study need further experimental verification, they should be interpreted with caution. However, we hope that this paper will provide new insights for the discovery of pathogenic genes and RA pathogenesis in the future. Cite this article: Bone Joint Res 2022;11(2):134–142.